Join our daily newsletter At The Bell to receive exclusive market insights
Good afternoon and welcome to HotCopper highlights for Week 4 of the year, I’m Jonathon Davidson. Let’s get into it.
There were lots of quarterlies this week and Liontown drew attention with strong production results. However, lithium prices remain depressed – or depressing – and the company’s former glory has truly re-rated.
Elsewhere, Carnarvon Energy released an update on its Dorado JV project it operates alongside Santos. While the JV says they’re committed to the project, it’s ditched plans to buy an offshore platform and a final investment decision has now been deferred with no firm timeline. That doesn’t sound very committed.
Finally, Clarity Pharmaceuticals made the boards after a second fast track status designation from the US FDA. The company’s copper-based PET scan imaging agent is of interest in the diagnosis of recurrent prostate cancer.
So that was the most viewed – but what about the most discussed?
Botanix remains popular on HotCopper as the company’s anti-sweating drug has brought patient shareholders big returns in the last twelve months.
Kogan generated some chatter with its quarterly on Friday, posting a return to strength.
Finally, Fortescue also made the boards, with its quarterly highlighting record iron ore production.
That’s HotCopper highlights for this week, I’m Jonathon Davidson, have a great weekend and we’ll see you on Monday.
